Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(27 sites)
United States
Noble Clinical Research, Tucson, Arizona Woodland International Research Group, Little Rock, Arkansas Woodland Research Northwest, Rogers, Arkansas Clinical Innovations Inc, Bellflower, California ProScience Research Group, Culver City, California ATP Clinical Research, Orange, California NRC Research Institute, Orange, California Clinical Innovations Inc, Riverside, California PharmaSouth Research, LLC, Coral Gables, Florida Clinical Neuroscience Solutions, Inc., Jacksonville, Florida Central Miami Medical Institute, Miami, Florida Clinical Neuroscience Solutions, Inc, Orlando, Florida Synexus Clinical Research, Inc., Atlanta, Georgia Atlanta Center for Medical Research, Atlanta, Georgia CenExel iResearch, Decatur, Georgia Denali Health Atlanta, LLC, Stone Mountain, Georgia Psychiatric Care and Research Center, O'Fallon, Missouri Redbird Clinical Research, LLC, Las Vegas, Nevada Lumina Clinical Research Center, Cherry Hill, New Jersey Integrative Clinical Trials LLC, Brooklyn, New York Neurobehavioral Research Inc, Cedarhurst, New York DelRicht Research, Charlotte, North Carolina Lehigh Center for Clinical Research, Allentown, Pennsylvania Clinical Neuroscience Solutions, Inc, Memphis, Tennessee Elevate Synapsis, LLC, Atascocita, Texas Grayline Research Center, Wichita Falls, Texas Eastside Therapeutics Resources, INC dba Core Clinical Research, Everett, Washington